Non-Hodgkins Lymphoma (NHL) Patients, With CD19+B Cell Lymphomas
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB13881 | Tisagenlecleucel | 2 | Completed | 1 |
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB13881 | Tisagenlecleucel | 2 | Completed | 1 |